Targeted Solutions for Viral Diseases

Using unprecedented knowledge of the antiviral nucleoside arena, Cocrystal Pharma’s therapies target high-mutating viral diseases such as Influenza, Hepatitis C, Norovirus and more.

View Product Pipeline


Our proprietary technologies enable the creation of first- and best-in-class antiviral products.

Learn More

Development Programs

Our development programs include a wide variety of serious and/or chronic viral diseases such as Influenza and Hepatitis C.

Learn More

About Us

Cocrystal Pharma uses proprietary and unique nucleoside chemistry combined with Nobel Prize winning expertise to target viral diseases.

Learn More

Investor Presentation

View our latest Corporate Presentation

View Presentation

Stock Data View Investor Relations

NASDAQ: COCP Loading...
Change Loading...
Volume Loading...
Market Cap Loading...